BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28315254)

  • 1. Live-Cell Imaging of Protease Activity: Assays to Screen Therapeutic Approaches.
    Chalasani A; Ji K; Sameni M; Mazumder SH; Xu Y; Moin K; Sloane BF
    Methods Mol Biol; 2017; 1574():215-225. PubMed ID: 28315254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathomimetic cancer avatars for live-cell imaging of protease activity.
    Ji K; Heyza J; Cavallo-Medved D; Sloane BF
    Biochimie; 2016 Mar; 122():68-76. PubMed ID: 26375517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatio-temporal modeling and live-cell imaging of proteolysis in the 4D microenvironment of breast cancer.
    Ji K; Sameni M; Osuala K; Moin K; Mattingly RR; Sloane BF
    Cancer Metastasis Rev; 2019 Sep; 38(3):445-454. PubMed ID: 31605250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAME models for 4D live-cell imaging of tumor: microenvironment interactions that impact malignant progression.
    Sameni M; Anbalagan A; Olive MB; Moin K; Mattingly RR; Sloane BF
    J Vis Exp; 2012 Feb; (60):. PubMed ID: 22371028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging Sites of Inhibition of Proteolysis in Pathomimetic Human Breast Cancer Cultures by Light-Activated Ruthenium Compound.
    Ramalho SD; Sharma R; White JK; Aggarwal N; Chalasani A; Sameni M; Moin K; Vieira PC; Turro C; Kodanko JJ; Sloane BF
    PLoS One; 2015; 10(11):e0142527. PubMed ID: 26562785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D/4D functional imaging of tumor-associated proteolysis: impact of microenvironment.
    Moin K; Sameni M; Victor BC; Rothberg JM; Mattingly RR; Sloane BF
    Methods Enzymol; 2012; 506():175-94. PubMed ID: 22341225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging and quantifying the dynamics of tumor-associated proteolysis.
    Sameni M; Cavallo-Medved D; Dosescu J; Jedeszko C; Moin K; Mullins SR; Olive MB; Rudy D; Sloane BF
    Clin Exp Metastasis; 2009; 26(4):299-309. PubMed ID: 19082919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live-Cell High Content Screening in Drug Development.
    Esner M; Meyenhofer F; Bickle M
    Methods Mol Biol; 2018; 1683():149-164. PubMed ID: 29082492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging proteolysis by living human breast cancer cells.
    Sameni M; Moin K; Sloane BF
    Neoplasia; 2000; 2(6):496-504. PubMed ID: 11228542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein Translocation Assays to Probe Protease Function and Screen for Inhibitors.
    Hahlbrock A; Gößwein D; Stauber RH
    Methods Mol Biol; 2017; 1574():227-241. PubMed ID: 28315255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-Based Assay Design for High-Content Screening of Drug Candidates.
    Nierode G; Kwon PS; Dordick JS; Kwon SJ
    J Microbiol Biotechnol; 2016 Feb; 26(2):213-25. PubMed ID: 26428732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging Proteolytic Activities in Mouse Models of Cancer.
    Pal A; Rehemtulla A
    Methods Mol Biol; 2018; 1731():247-260. PubMed ID: 29318559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying the autophagy-triggering effects of drugs in cell spheroids with live fluorescence microscopy.
    Ansari N; Hardung S; Hötte K; Rakel S; Antonietti P; Kögel D; Stelzer EH; Pampaloni F
    Methods Mol Biol; 2014; 1165():19-29. PubMed ID: 24839016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-content screening of natural products reveals novel nuclear export inhibitors.
    Cautain B; de Pedro N; Murillo Garzón V; Muñoz de Escalona M; González Menéndez V; Tormo JR; Martin J; El Aouad N; Reyes F; Asensio F; Genilloud O; Vicente F; Link W
    J Biomol Screen; 2014 Jan; 19(1):57-65. PubMed ID: 24045581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Throughput Whole-Plate Imaging of Cells for Multiple Biological Applications.
    Sukumar UK; Habte F; Massoud TF; Paulmurugan R
    Methods Mol Biol; 2021; 2274():367-384. PubMed ID: 34050486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional imaging of tumor proteolysis.
    Sloane BF; Sameni M; Podgorski I; Cavallo-Medved D; Moin K
    Annu Rev Pharmacol Toxicol; 2006; 46():301-15. PubMed ID: 16402907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolysis-a characteristic of tumor-initiating cells in murine metastatic breast cancer.
    Hillebrand LE; Bengsch F; Hochrein J; Hülsdünker J; Bender J; Follo M; Busch H; Boerries M; Reinheckel T
    Oncotarget; 2016 Sep; 7(36):58244-58260. PubMed ID: 27542270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring protease activity in biological tissues using antibody prodrugs as sensing probes.
    Vasiljeva O; Menendez E; Nguyen M; Craik CS; Michael Kavanaugh W
    Sci Rep; 2020 Apr; 10(1):5894. PubMed ID: 32246002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D Cell-Based Assays for Drug Screens: Challenges in Imaging, Image Analysis, and High-Content Analysis.
    Booij TH; Price LS; Danen EHJ
    SLAS Discov; 2019 Jul; 24(6):615-627. PubMed ID: 30817892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly multiplexed phenotypic imaging for cell proliferation studies.
    Cappella P; Gasparri F
    J Biomol Screen; 2014 Jan; 19(1):145-57. PubMed ID: 23896684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.